1. Stoner, Samuel A, Liu, Katherine Tin Heng, Andrews, Elizabeth T, Carter, Hannah, Zhang, Dong-Er. 2020. The RUNX1-ETO target gene RASSF2 suppresses t(8;21) AML development and regulates Rac GTPase signaling. In Blood cancer journal, 10, 16. doi:10.1038/s41408-020-0282-9. https://pubmed.ncbi.nlm.nih.gov/32029705/
2. Zhou, Kena, Cai, Congbo, He, Yi, Ding, Xiaoyun, Duan, Shiwei. 2019. Association Between RASSF2 Methylation and Gastric Cancer: A PRISMA-Compliant Systematic Review and Meta-Analysis. In DNA and cell biology, 38, 1147-1154. doi:10.1089/dna.2019.4922. https://pubmed.ncbi.nlm.nih.gov/31453724/
3. Kaira, Kyoichi, Sunaga, Noriaki, Tomizawa, Yoshio, Nakajima, Takashi, Mori, Masatomo. . Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers. In International journal of oncology, 31, 169-73. doi:. https://pubmed.ncbi.nlm.nih.gov/17549418/
4. Perez-Janices, Noemi, Blanco-Luquin, Idoia, Torrea, Natalia, Lera, José Miguel, Guerrero-Setas, David. . Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis. In Oncotarget, 6, 23944-58. doi:. https://pubmed.ncbi.nlm.nih.gov/26284587/
5. Riffet, Marc, Eid, Yassine, Faisant, Maxime, Levallet, Guénaelle, Bazille, Céline. 2021. Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers. In Cancers, 13, . doi:10.3390/cancers13235957. https://pubmed.ncbi.nlm.nih.gov/34885067/
智鼠故事 
